Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem
COVID-19 vaccine risk-benefit ratio favourable for patients with rheumatic diseases
In the CONVIN-SING* study, there was a favourable risk-benefit ratio for COVID-19 vaccination in individuals with autoimmune inflammatory rheumatic diseases (AIIRD) who have received a COVID-19 mRNA vaccine.
Hands-free, pocket-size device helps ease breathing for people with COPD
A small positive-expiratory pressure (PEP) device that can be used on-demand shows promise for improving the lives of people with chronic obstructive pulmonary disease (COPD), according to a study.
Chemotherapy plus ICI treatment ups VTE risk in cancer patients
Combination treatment with immune checkpoint inhibitors (ICI) and chemotherapy is associated with a higher risk of venous thromboembolic events (VTE) in adult cancer patients, reveals a study. In addition, a similar VTE disease course is seen after ICI exposure, irrespective of other immune-related adverse events (irAEs).
Oral, on-the-skin immunotherapies show promise against peanut allergy in children
Children who are allergic to peanuts may benefit from two immunotherapies, one oral and another epicutaneous or on-the-skin, which have demonstrated safety and efficacy in separate studies presented at the recent AAAAI 2023.
CAB+RPV LA vs B/FTC/TAF for HIV: Which is better?
In virologically suppressed adults with HIV, the cabotegravir + rilpivirine long-acting (CAB+RPV LA) regimen was on par with bictegravir/emtricitabine/tenofovir alafenamide (B/FTC/TAF) in terms of virologic efficacy, but the former gained the upper hand over the latter in terms of patient satisfaction and preference, the SOLAR* study reports.
